Cardlytics (NASDAQ:CDLX) CEO Sells $41,997.87 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 45,159 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $0.93, for a total transaction of $41,997.87. Following the sale, the chief executive officer directly owned 659,644 shares in the company, valued at $613,468.92. This trade represents a 6.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The stock was sold at an average price of $0.90, for a total value of $46,844.10.
• On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total value of $6,794.19.

Cardlytics Stock Up 2.4%

NASDAQ CDLX opened at $0.91 on Friday. The stock has a market capitalization of $49.07 million, a P/E ratio of -0.43, a price-to-earnings-growth ratio of 0.14 and a beta of 1.03. Cardlytics, Inc. has a 52 week low of $0.80 and a 52 week high of $3.28. The company has a debt-to-equity ratio of 2.87, a quick ratio of 1.14 and a current ratio of 1.14. The stock has a fifty day moving average of $1.09 and a 200-day moving average of $1.39.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CDLX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a research note on Monday, December 29th. Wall Street Zen lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Three equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $2.25.

Institutional Trading of Cardlytics

Hedge funds have recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC acquired a new position in Cardlytics during the third quarter valued at approximately $26,000. Catalyst Funds Management Pty Ltd bought a new position in shares of Cardlytics during the second quarter worth $32,000. Sand Hill Global Advisors LLC acquired a new position in shares of Cardlytics in the 2nd quarter valued at $35,000. Y Intercept Hong Kong Ltd acquired a new position in shares of Cardlytics in the 2nd quarter valued at $42,000. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Cardlytics in the 3rd quarter valued at $55,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.